A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

Clinical trial NCT02936102 · TERMINATED

Trial details

NCT number: NCT02936102
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Triple Negative Breast Cancer Chordoma and Alveolar Soft Part Sarcoma

Start date: 2016-10-20
Primary completion: 2024-11-22
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.